These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11737255)

  • 21. Autologous stem-cell transplantation in multiple myeloma.
    Gahrton G
    Wien Med Wochenschr; 1995; 145(2-3):52-4. PubMed ID: 7762254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The importance of autologous transplantation in multiple myeloma].
    Pour L; Hájek R; Adam Z; Krejcí M; Vorlícek J
    Vnitr Lek; 2009 Sep; 55(9):767-72. PubMed ID: 19785373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transplantation in multiple myeloma.
    Topolsky D; Biggs D
    Semin Oncol; 1995 Jun; 22(3):230-7. PubMed ID: 7777867
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of autologous stem-cell transplantation in multiple myeloma.
    Attal M; Harousseau JL
    Best Pract Res Clin Haematol; 2007 Dec; 20(4):747-59. PubMed ID: 18070717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Con: allogeneic transplantation in multiple myeloma.
    van Rhee F
    Clin Adv Hematol Oncol; 2006 May; 4(5):391-4. PubMed ID: 16728948
    [No Abstract]   [Full Text] [Related]  

  • 26. Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma.
    Veltri LW; Milton DR; Delgado R; Shah N; Patel K; Nieto Y; Kebriaei P; Popat UR; Parmar S; Oran B; Ciurea S; Hosing C; Lee HC; Manasanch E; Orlowski RZ; Shpall EJ; Champlin RE; Qazilbash MH; Bashir Q
    Cancer; 2017 Sep; 123(18):3568-3575. PubMed ID: 28513828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allografting or autografting for myeloma.
    Moreau P; Harousseau JL; Attal M
    N Engl J Med; 2007 Jun; 356(25):2646-8; author reply 2646-8. PubMed ID: 17600892
    [No Abstract]   [Full Text] [Related]  

  • 28. Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma.
    Huang J; Phillips S; Byrne M; Chinratanalab W; Engelhardt BG; Goodman SA; Harrell SL; Jagasia M; Kassim A; Rawling KT; Savani BN; Sengsayadeth S; Cornell RF
    Bone Marrow Transplant; 2018 Jun; 53(6):701-707. PubMed ID: 29703965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myeloma: what have we learned?
    Bergsagel DE
    Biomed Pharmacother; 2001 Nov; 55(9-10):548-9. PubMed ID: 11769964
    [No Abstract]   [Full Text] [Related]  

  • 30. New strategies in transplantation therapy.
    Harousseau JL
    Oncology (Williston Park); 2004 Nov; 18(13):1614-5, 1617. PubMed ID: 15648294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of melphalan in myeloma patients undergoing an autograft.
    Nath CE; Shaw PJ; Trotman J; Zeng L
    Bone Marrow Transplant; 2007 Oct; 40(7):707-8. PubMed ID: 17680022
    [No Abstract]   [Full Text] [Related]  

  • 32. Impact of novel agents followed by autologous hematopoietic stem cell transplantation for multiple myeloma patients aged 65 years or older: a retrospective single Institutional analysis.
    Minoia C; Pisapia G; Palazzo G; Ingrosso C; Buonanno M; Spinosa C; Prudenzano A; Pricolo G; Mazza P
    Bone Marrow Transplant; 2015 Nov; 50(11):1486. PubMed ID: 26281030
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of outcomes after autologous stem cell transplantation between myeloma patients with skeletal and soft tissue plasmacytoma.
    Shin HJ; Kim K; Lee JW; Song MK; Lee JJ; Lee HS; Lee WS; Kim SJ; Chung JS
    Eur J Haematol; 2014 Nov; 93(5):414-21. PubMed ID: 24813053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [High-dosage chemotherapy with support of autologous haematopoietic cells in the treatment of multiple myeloma--review of contemporary possibilities].
    Rácil Z; Adam Z; Hájek R; Tomíska M; Krejcí M; Krivanová A; Höklová J; Doubek M; Mayer J; Vorlícek J
    Vnitr Lek; 2001 Feb; 47(2):92-8. PubMed ID: 15635853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poor autologous mobilization status does not impact on hematological recovery but affects outcome after allogeneic stem cell transplant for lymphoma and myeloma.
    Crocchiolo R; Chabannon C; El-Cheikh J; Esterni B; Lemarié C; Fürst S; Castagna L; Bouabdallah R; Ladaique P; Coso D; Schiano JM; Stoppa AM; Rey J; Ivanov V; Aurran T; Faucher C; Blaise D; Calmels B
    Leuk Lymphoma; 2013 Feb; 54(2):417-20. PubMed ID: 22702654
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of multiple myeloma: the changing landscape.
    Reece DE
    Blood Rev; 2007 Nov; 21(6):301-14. PubMed ID: 17761373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autologous hematopoietic stem cell transplantation for multiple myeloma: frequently asked questions.
    Mangan PA; Gleason CL; Miceli T
    Clin J Oncol Nurs; 2013 Dec; 17 Suppl():43-7. PubMed ID: 24280458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to salvage therapies and outcome in patients with multiple myeloma relapsing after pomalidomide therapy.
    Sinha S; Lacy M; Mikhael J; Hayman S; Buadi F; Detweiler-Short K; Dispenzieri A; Gertz M; Dingli D; Rajkumar SV; Kumar SK
    Leukemia; 2012 Apr; 26(4):839-41. PubMed ID: 21986842
    [No Abstract]   [Full Text] [Related]  

  • 39. Intra-cerebral relapse following prolonged remission after autologous stem cell transplantation for multiple myeloma.
    Seftel MD; Maguire J; Voss N; Woodhurst WB; Dalal BI; Shepherd JD
    Leuk Lymphoma; 2002 Dec; 43(12):2399-403. PubMed ID: 12613531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma.
    Barlogie B; Alexanian R
    Cancer Res; 1989 Dec; 49(24 Pt 1):7172-5. PubMed ID: 2479477
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.